Nicole R. Hadas

Insider Reports History

Location
Winchester, MA
Signature
/s/ Carolyn Rucci, attorney-in-fact for Nicole R. Hadas
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Nicole R. Hadas:

Company Role Class Num Shares Value Price $ Report Date Ownership
Akebia Therapeutics, Inc. SVP, Chief Legal Officer Common Stock 651,243 $820,566 $1.26 13 May 2024 Direct
Akebia Therapeutics, Inc. SVP, Chief Legal Officer Stock Option (Right to buy) 224,000 31 Jan 2024 Direct

Insider Reports Filed by Nicole R. Hadas

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AKBA Akebia Therapeutics, Inc. 13 May 2024 1 -$15,140 4 SVP, Chief Legal Officer 14 May 2024, 16:05
AKBA Akebia Therapeutics, Inc. 29 Feb 2024 1 -$9,439 4 SVP, Chief Legal Officer 01 Mar 2024, 17:48
AKBA Akebia Therapeutics, Inc. 27 Feb 2024 1 -$11,265 4 SVP, Chief Legal Officer 29 Feb 2024, 18:03
AKBA Akebia Therapeutics, Inc. 31 Jan 2024 2 $0 4 SVP, Chief Legal Officer 02 Feb 2024, 16:10
AKBA Akebia Therapeutics, Inc. 24 May 2023 3 -$77,270 4 SVP, Chief Legal Officer 25 May 2023, 21:01
AKBA Akebia Therapeutics, Inc. 12 May 2023 1 $0 4 SVP, Chief Legal Officer 16 May 2023, 16:10
AKBA Akebia Therapeutics, Inc. 01 Mar 2023 3 -$11,437 4 SVP, Chief Legal Officer 03 Mar 2023, 07:01
AKBA Akebia Therapeutics, Inc. 27 Feb 2023 1 -$5,430 4 SVP, Chief Legal Officer 01 Mar 2023, 15:05
AKBA Akebia Therapeutics, Inc. 28 Feb 2022 6 -$45,615 4 SVP, Chief Legal Officer 02 Mar 2022, 20:10